KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biomarin Pharmaceutical (BMRN) Interest Coverage Ratio (2017 - 2025)

Historic Interest Coverage Ratio for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Q3 2025 value amounting to 18.1.

  • Biomarin Pharmaceutical's Interest Coverage Ratio fell 14718.0% to 18.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 57.53, marking a year-over-year increase of 16601.96%. This contributed to the annual value of 38.23 for FY2024, which is 25672.76% up from last year.
  • Biomarin Pharmaceutical's Interest Coverage Ratio amounted to 18.1 in Q3 2025, which was down 14718.0% from 103.35 recorded in Q2 2025.
  • Biomarin Pharmaceutical's Interest Coverage Ratio's 5-year high stood at 103.35 during Q2 2025, with a 5-year trough of 18.1 in Q3 2025.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 10.15 (2022), whereas its average is 20.57.
  • As far as peak fluctuations go, Biomarin Pharmaceutical's Interest Coverage Ratio skyrocketed by 166370.63% in 2023, and later plummeted by 14718.0% in 2025.
  • Over the past 5 years, Biomarin Pharmaceutical's Interest Coverage Ratio (Quarter) stood at 17.13 in 2021, then skyrocketed by 78.93% to 3.61 in 2022, then skyrocketed by 223.94% to 4.47 in 2023, then soared by 1300.13% to 62.63 in 2024, then crashed by 128.91% to 18.1 in 2025.
  • Its Interest Coverage Ratio stands at 18.1 for Q3 2025, versus 103.35 for Q2 2025 and 78.2 for Q1 2025.